Yu, H.; Liu, M.; Hou, S.; Wu, J.; Du, Q.; Feng, F.; Wang, S.; Wang, C.; Xu, K.
Jaceosidin Attenuates Sepsis-Induced Myocardial Dysfunction by Promoting SIRT2-Mediated Inhibition of Histone H3K18 Lactylation. Pharmaceuticals 2026, 19, 97.
https://doi.org/10.3390/ph19010097
AMA Style
Yu H, Liu M, Hou S, Wu J, Du Q, Feng F, Wang S, Wang C, Xu K.
Jaceosidin Attenuates Sepsis-Induced Myocardial Dysfunction by Promoting SIRT2-Mediated Inhibition of Histone H3K18 Lactylation. Pharmaceuticals. 2026; 19(1):97.
https://doi.org/10.3390/ph19010097
Chicago/Turabian Style
Yu, Huiming, Minfu Liu, Shuwan Hou, Jiaqin Wu, Qianqian Du, Fan Feng, Sixiang Wang, Chunli Wang, and Kang Xu.
2026. "Jaceosidin Attenuates Sepsis-Induced Myocardial Dysfunction by Promoting SIRT2-Mediated Inhibition of Histone H3K18 Lactylation" Pharmaceuticals 19, no. 1: 97.
https://doi.org/10.3390/ph19010097
APA Style
Yu, H., Liu, M., Hou, S., Wu, J., Du, Q., Feng, F., Wang, S., Wang, C., & Xu, K.
(2026). Jaceosidin Attenuates Sepsis-Induced Myocardial Dysfunction by Promoting SIRT2-Mediated Inhibition of Histone H3K18 Lactylation. Pharmaceuticals, 19(1), 97.
https://doi.org/10.3390/ph19010097